✦ LIBER ✦

Colonoscopy Is More Helpful Than Sigmoidoscopy to Diagnose GVHD in Patients with Allogenic Hematopoietic Stem Cell Transplantation (aHSCT)

✍ Scribed by Kyung Jo Kim; Hye-Won Park; Dong-Hoon Yang; Mi Young Do; Soon Man Yoon; Byong Duk Ye; Jeong-Sik Byeon; Jin-Ho Kim; Seung-Jae Myung; Suk-Kyun Yang

Book ID: 119248184
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 63 KB
Volume: 69
Category: Article
ISSN: 1097-6779
DOI: 10.1016/j.gie.2009.03.784

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Procalcitonin Measurements to Dia

Use of Procalcitonin Measurements to Diagnose infection in Allogeneic Hematopoietic Stem Cell Transplantation Patients With Fever

✍ S. Kohashi; Y. Nawa; E. Matsubara; K. Nakase; M. Hara 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Time to engraftment following allogeneic

Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia

✍ Bitan, M; Or, R; Shapira, M Y; Resnick, I B; Gesundheit, B; Ackerstein, A; Samue 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB

Long-Term Follow-Up of Patients After Al

Long-Term Follow-Up of Patients After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Regard to QOL and Social Functioning in Chronic GVHD: A Single-Institute Analysis

✍ A. Mori; M. Yamada; N. Wada; E. Fujii; M. Mori; R. Tanosaki; S. Yamamoto; M. Ara 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Blast Percentage Prior to Transplantatio

Blast Percentage Prior to Transplantation Is the Strongest Predictive Factor for Survival After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Patients with Myelodysplastic Syndrome (MDS)

✍ A.M. Jimenez; E.S. Rich; S. Nathan; J. Maciejewski; J.M. Shammo; D. Katz; E. Bra 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

In CML Patients, Residual Disease In Pri

In CML Patients, Residual Disease In Primitive Stem/Progenitor Cells Following Allogeneic Stem Cell Transplantation Is Higher Than After Treatment With Tyrosine Kinase Inhibitors Alone, But Is Still Amenable To GVL Effects

✍ A.S.M. Yong; K. Keyvanfar; R. Eniafe; B.N. Savani; K. Rezvani; A. Shenoy; E.K. K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

CD34+ Cell Dose and Full Donor Chimerism

CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies

✍ S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB